BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 24762807)

  • 21. Risk factors for electrocardiographic left ventricular hypertrophy in a young Chinese general population: the Hanzhong adolescent cohort study.
    Liao YY; Gao K; Fu BW; Yang L; Zhu WJ; Ma Q; Chu C; Yan Y; Wang Y; Zheng WL; Hu JW; Wang KK; Sun Y; Chen C; Mu JJ
    BMC Cardiovasc Disord; 2021 Mar; 21(1):159. PubMed ID: 33789587
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension.
    Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Gattobigio R; Zampi I; Porcellati C
    J Am Coll Cardiol; 1998 Feb; 31(2):383-90. PubMed ID: 9462583
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Four ECG left ventricular hypertrophy criteria and the risk of cardiovascular events and mortality in patients with vascular disease.
    van Kleef MEAM; Visseren FLJ; Vernooij JWP; Nathoe HM; Cramer MM; Bemelmans RHH; van der Graaf Y; Spiering W;
    J Hypertens; 2018 Sep; 36(9):1865-1873. PubMed ID: 29878973
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Left ventricular hypertrophy on electrocardiogram: prognostic implications from a 10-year cohort study of older subjects: a report from the Bronx Longitudinal Aging Study.
    Kahn S; Frishman WH; Weissman S; Ooi WL; Aronson M
    J Am Geriatr Soc; 1996 May; 44(5):524-9. PubMed ID: 8617900
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Electrocardiographic left ventricular hypertrophy predicts recurrence of atrial arrhythmias after catheter ablation of paroxysmal atrial fibrillation.
    Li SN; Wang L; Dong JZ; Yu RH; Long DY; Tang RB; Sang CH; Jiang CX; Liu N; Bai R; Du X; Ma CS
    Clin Cardiol; 2018 Jun; 41(6):797-802. PubMed ID: 29604089
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ECG left ventricular hypertrophy is a stronger risk factor for incident cardiovascular events in women than in men in the general population.
    Porthan K; Niiranen TJ; Varis J; Kantola I; Karanko H; Kähönen M; Nieminen MS; Salomaa V; Huikuri HV; Jula AM
    J Hypertens; 2015 Jun; 33(6):1284-90. PubMed ID: 25764049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of electrocardiographic left ventricular hypertrophy with incident cardiovascular disease in Japanese older hypertensive patients.
    Edison ES; Yano Y; Hoshide S; Kario K
    Am J Hypertens; 2015 Apr; 28(4):527-34. PubMed ID: 25267736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic implications of left ventricular hypertrophy diagnosed on electrocardiogram vs echocardiography.
    Pedersen LR; Kristensen AMD; Petersen SS; Vaduganathan M; Bhatt DL; Juel J; Byrne C; Leósdóttir M; Olsen MH; Pareek M
    J Clin Hypertens (Greenwich); 2020 Sep; 22(9):1647-1658. PubMed ID: 32813895
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combining ECG Criteria for Left Ventricular Hypertrophy Improves Risk Prediction in Patients With Hypertension.
    Okin PM; Hille DA; Kjeldsen SE; Devereux RB
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29151037
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation of QT interval and QT dispersion to echocardiographic left ventricular hypertrophy and geometric pattern in hypertensive patients. The LIFE study. The Losartan Intervention For Endpoint Reduction.
    Oikarinen L; Nieminen MS; Viitasalo M; Toivonen L; Wachtell K; Papademetriou V; Jern S; Dahlöf B; Devereux RB; Okin PM
    J Hypertens; 2001 Oct; 19(10):1883-91. PubMed ID: 11593111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and long-term prognostic implications of prolonged QRS duration in left ventricular hypertrophy: a population-based observational cohort study.
    Rankinen J; Haataja P; Lyytikäinen LP; Huhtala H; Lehtimäki T; Kähönen M; Eskola M; Tuohinen S; Pérez-Riera AR; Jula A; Rissanen H; Nikus K; Hernesniemi J
    BMJ Open; 2022 Feb; 12(2):e053477. PubMed ID: 35228283
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of Electrocardiography to Predict Future Development of Hypertension in the General Population.
    Takase H; Sugiura T; Murai S; Yamashita S; Ohte N; Dohi Y
    Medicine (Baltimore); 2016 Apr; 95(17):e3483. PubMed ID: 27124047
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Electrocardiographic Left Ventricular Hypertrophy Predicts Cardiovascular Morbidity and Mortality in Hypertensive Patients: The ALLHAT Study.
    Bang CN; Soliman EZ; Simpson LM; Davis BR; Devereux RB; Okin PM;
    Am J Hypertens; 2017 Sep; 30(9):914-922. PubMed ID: 28430947
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of QT-interval parameters for cardiovascular risk stratification in type 2 diabetic patients with arterial hypertension.
    Salles GF; Deccache W; Cardoso CR
    J Hum Hypertens; 2005 Mar; 19(3):241-9. PubMed ID: 15660120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Electrocardiographic Left Ventricular Hypertrophy as a Predictor of Cardiovascular Disease Independent of Left Ventricular Anatomy in Subjects Aged ≥65 Years.
    Leigh JA; O'Neal WT; Soliman EZ
    Am J Cardiol; 2016 Jun; 117(11):1831-5. PubMed ID: 27067620
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determinants and prognostic significance of electrocardiographic left ventricular hypertrophy criteria in chronic kidney disease.
    Agarwal R; Light RP
    Clin J Am Soc Nephrol; 2011 Mar; 6(3):528-36. PubMed ID: 21088286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of electrocardiographic and imaging surrogates of left ventricular hypertrophy with incident atrial fibrillation: MESA (Multi-Ethnic Study of Atherosclerosis).
    Chrispin J; Jain A; Soliman EZ; Guallar E; Alonso A; Heckbert SR; Bluemke DA; Lima JA; Nazarian S
    J Am Coll Cardiol; 2014 May; 63(19):2007-13. PubMed ID: 24657688
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discrepancy between left ventricular hypertrophy by echocardiography and electrocardiographic hypertrophy: clinical characteristics and outcomes.
    Seko Y; Kato T; Yamaji Y; Haruna Y; Nakane E; Haruna T; Inoko M
    Open Heart; 2021 Sep; 8(2):. PubMed ID: 34556560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiparametric electrocardiographic evaluation of left ventricular hypertrophy in idiopathic and hypertensive cardiomyopathy.
    Lazzeri C; Barletta G; Badia T; Capalbio A; Del Bene R; Franchi F; Gensini GF; Michelucci A
    Ital Heart J; 2005 Apr; 6(4):304-10. PubMed ID: 15902928
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diagnostic and prognostic utility of electrocardiography for left ventricular hypertrophy defined by magnetic resonance imaging in relationship to ethnicity: the Multi-Ethnic Study of Atherosclerosis (MESA).
    Jain A; Tandri H; Dalal D; Chahal H; Soliman EZ; Prineas RJ; Folsom AR; Lima JA; Bluemke DA
    Am Heart J; 2010 Apr; 159(4):652-8. PubMed ID: 20362725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.